These tips for investing in mutual funds and ETFs can elevate your portfolio
By MarketWatch
This week: Retirement planning with target-date funds; fighting inflation with TIPS funds, and tapping into growth trends and buyouts
Don't miss these top money and investing features:
This fund has outperformed with stocks that are ripe targets for other companiesDoes owning more stocks in retirement give you the financial security you need?This is the best hedge against unexpected inflation. It's not what you think.
Sign up here to get MarketWatch's highlights of the most timely ETF news emailed to you weekly!
INVESTING NEWS & TRENDS
This fund has outperformed with stocks that are ripe targets for other companies
Here's a look at another strategy that continues a series of articles about ways to diversify beyond broad index strategies in the stock market. Read More
Eight stock picks in AI, obesity drugs, e-commerce and other growth areas beyond the S&P 500
Nicole Kornitzer of Buffalo Funds explains how she invests in "secular growth trends that can last a number of years." Read More
Does owning more stocks in retirement give you the financial security you need?
How much is enough? The 10 largest target-date 2020 mutual funds offer some answers. Read More
This chart shows the 'dangerous' stock-market risk Baby Boomers could be facing
The view that markets always go up over time is a dangerous one, especially for older investors, says Andrew Adams, strategist at Saut Strategy. Read More
Big pharma is looking to fatten profits with buyouts of weight-loss drug companies. Here are 4 candidates.
Even if they're not acquired, these small companies are developing promising obesity and diabetes treatments. Read More
Here's what the S&P 500's 50-day moving average is telling us now about stocks
The once-reliable market-timing indicator has lost its predictive power. Read More
Do cash-gushing stocks outperform the S&P 500? Here's what history has to say.
Here's how selecting stocks five years ago by FCF yield would have worked out. Read More
Bearish insiders, bullish investors and global conflict are red flags for stocks
This market is vulnerable - and not because of inflation, the Fed or the election. Read More
This is the best hedge against unexpected inflation. It's not what you think.
Gold is not the best hedge against unexpected inflation. Neither is bitcoin. Read More
Nvidia is the No. 1 S&P 500 growth stock in this screen. See which other companies joined or left the list.
An updated screen of the S&P 500 by expected growth rates for sales, earnings and cash flow shows many changes from last year's list. Read More
'If you and your money went to therapy': Advisers now want to know about your fears, conflicts and dying wishes
Beliefs, experiences and family dynamics influence money decisions. Read More
Here's a simple stock-market timing system you can use that beats all the others
'Seasonality Timing System' shifts into and out of stocks using nothing more than the calendar. Read More
-MarketWatch
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
04-18-24 1417ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Powell Unfazed By Sticky Inflation, but Rate Cuts Are Far Off
-
After Earnings, Is Microsoft Stock a Buy, a Sell, or Fairly Valued?
-
Best- and Worst-Performing Stocks of April 2024
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
10 Top-Performing Dividend Stocks of the Month
-
Marathon Petroleum Earnings: No Change to Competitive Position, but Shares Look Expensive
-
Charlie Munger and How Not to Invest
-
Look Inside Berkshire Hathaway’s Portfolio Before Its Annual Meeting
-
After Earnings, Is AT&T Stock a Buy, a Sell, or Fairly Valued?
-
Mastercard Earnings: A Stable Environment Highlights the Firm’s Strengths
-
Pfizer Earnings: Solid Results Supported by Steady Tracking Toward $4 Billion In Cost Cuts
-
Starbucks Earnings: Not a Lot to Like About Results as Global Traffic Sputters